Comparison of darolutamide vs apalutamide and enzalutamide
Oncología

Indirect comparison of darolutamide versus apalutamide and enzalutamide for non-metastatic castration-resistant prostate cancer.

Halabi S, Jiang S. Terasawas E. et al. J Urol. 2021 Apr 5.

Related Content
Darolutamide and health-related QoL in ARAMIS
CPRCnm
EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guías 2022 I
Cáncer de próstata
EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guías 2022 II
Cáncer de próstata